References for this PMC Article for PMID: 19538743

Year	Number of Results
1979	1
1983	1
1986	1
1990	1
1992	1
1993	1
1994	1
1996	1
1997	1
1998	3
1999	1
2000	1
2001	5
2002	2
2003	1
2007	5
2008	1
2009	1
2024	0

1

Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres.

Murata Y, Lightfoote PM, Rose RC, Walsh EE. Murata Y, et al. Virol J. 2009 Jun 18;6:81. doi: 10.1186/1743-422X-6-81. Virol J. 2009. PMID: 19538743 Free PMC article.

2

A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response.

Thönes N, Herreiner A, Schädlich L, Piuko K, Müller M. Thönes N, et al. J Virol. 2008 Jun;82(11):5472-85. doi: 10.1128/JVI.02482-07. Epub 2008 Apr 2. J Virol. 2008. PMID: 18385253 Free PMC article.

3

Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches.

Wu SJ, Schmidt A, Beil EJ, Day ND, Branigan PJ, Liu C, Gutshall LL, Palomo C, Furze J, Taylor G, Melero JA, Tsui P, Del Vecchio AM, Kruszynski M. Wu SJ, et al. J Gen Virol. 2007 Oct;88(Pt 10):2719-2723. doi: 10.1099/vir.0.82753-0. J Gen Virol. 2007. PMID: 17872524

4

Virus-like particles: flexible platforms for vaccine development.

Chackerian B. Chackerian B. Expert Rev Vaccines. 2007 Jun;6(3):381-90. doi: 10.1586/14760584.6.3.381. Expert Rev Vaccines. 2007. PMID: 17542753 Review.

5

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Garland SM, et al. N Engl J Med. 2007 May 10;356(19):1928-43. doi: 10.1056/NEJMoa061760. N Engl J Med. 2007. PMID: 17494926 Free article. Clinical Trial.

6

Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.

Ryding J, Dahlberg L, Wallen-Öhman M, Dillner J. Ryding J, et al. J Gen Virol. 2007 Mar;88(Pt 3):792-802. doi: 10.1099/vir.0.82449-0. J Gen Virol. 2007. PMID: 17325351

7

Structure-based engineering of papillomavirus major capsid l1: controlling particle assembly.

Bishop B, Dasgupta J, Chen XS. Bishop B, et al. Virol J. 2007 Jan 8;4:3. doi: 10.1186/1743-422X-4-3. Virol J. 2007. PMID: 17210082 Free PMC article.

8

Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.

Varsani A, Williamson AL, de Villiers D, Becker I, Christensen ND, Rybicki EP. Varsani A, et al. J Virol. 2003 Aug;77(15):8386-93. doi: 10.1128/jvi.77.15.8386-8393.2003. J Virol. 2003. PMID: 12857908 Free PMC article.

9

A controlled trial of a human papillomavirus type 16 vaccine.

Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU; Proof of Principle Study Investigators. Koutsky LA, et al. N Engl J Med. 2002 Nov 21;347(21):1645-51. doi: 10.1056/NEJMoa020586. N Engl J Med. 2002. PMID: 12444178 Free article. Clinical Trial.

10

Atomic model of the papillomavirus capsid.

Modis Y, Trus BL, Harrison SC. Modis Y, et al. EMBO J. 2002 Sep 16;21(18):4754-62. doi: 10.1093/emboj/cdf494. EMBO J. 2002. PMID: 12234916 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year